S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
798 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Nacional de Cancerologia de Mexico
Tlalpan, Mexico
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- Gulf Coast Mbccop
Mobile, Alabama, United States
- Providence Hospital
Mobile, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- the University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- the University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- the University of Arizona Medical Center-University Campus
Tucson, Arizona, United States
- Fowler Family Center for Cancer Care
Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- East Bay Medical Oncology Hematology Medical Associates-Antioch
Antioch, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills - Peninsula Hospitals
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- Enloe Medical Center
Chico, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Northbay Cancer Center
Fairfield, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Mather Veteran Affairs Medical Center
Mather, California, United States
- Mercy Uc Davis Cancer Center
Merced, California, United States
- Memorial Medical Center
Modesto, California, United States
- El Camino Hospital
Mountain View, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jul 2009
- Primary completion
- 31 Aug 2017
- Completion
- 8 Feb 2022
- Last update posted
- 23 May 2023
- Registered enrollment
- 1,333
- Registry id
- NCT00946712
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.